A new daunomycin-peptide conjugate: Synthesis, characterization and the effect on the protein expression profile of HL-60 cells in vitro

Bioconjugate Chemistry

Volumn 22, Issue 10, 2011, Pages 2154-2165

  Orbán, Erika ^a   Manea, Marilena ^b   Marquadt, Andreas ^b   Bánóczi, Zoltán ^a   Csik, Gabriella ^c   Fellinger, Erzsébet ^d   Bõsze, Szilvia ^a   Hudecz, Ferenc ^a,d  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; DISEASES;

ACUTE MYELOID LEUKEMIA; ANTINEOPLASTIC AGENTS; CYTOSTATIC; DAUNOMYCIN; DNA-BINDING; HL-60 CELLS; HUMAN CANCER CELLS; IN-VITRO; OSTEOSARCOMAS; PROTEIN EXPRESSION PROFILES;

PEPTIDES;

BETA TUBULIN; DAUNORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; OLIGOPEPTIDE;

ARTICLE; CELL STRAIN HL 60; CYTOSTASIS; CYTOTOXICITY; DNA BINDING; DRUG CONJUGATION; DRUG DEGRADATION; DRUG PROTEIN BINDING; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

RATTUS;

EID: 80054796111     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc2004236     Document Type: Article

References (50)

1. Wiernik, P. H. and Dutcher, J. P. (1992) Clinical importance of anthracyclines in the treatment of acute myeloid leukemia Leukemia 6 Suppl 1, 67-9
2. Takimoto, C. H. and Calvo, E. (2008) Principles of Oncologic Pharmacotherapy. In Cancer Management: A Multidisciplinary Approach, 11 th ed., Chapter 3.
3. Von Hoff, D. D., Rozencweig, M., Layard, M., Slavik, M., and Muggia, F. M. (1977) Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases Am. J. Med. 62, 200-8 (Pubitemid 8042834)
4. Riehm, H. and Biedler, J. L. (1971) Cellular resistance to daunomycin in Chinese hamster cells in vitro Cancer Res. 31, 409-12
5. Shen, S. H., Gu, L. J., Liu, P. Q., Ye, X., Chang, W. S., and Li, B. S. (2008) Comparative proteomic analysis of differentially expressed proteins between K562 and K562/ADM cells Chin. Med. J. (Engl.) 121, 463-8 (Pubitemid 351565996)
6. Keenan, J., Murphy, L., Henry, M., Meleady, P., and Clynes, M. (2009) Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell line Proteomics 9, 1556-66
7. Yang, Y. X., Hu, H. D., Zhang, D. Z., and Ren, H. (2007) Identification of proteins responsible for the development of adriamycin resistance in human gastric cancer cells using comparative proteomics analysis J. Biochem. Mol. Biol. 40, 853-60 (Pubitemid 350242268)
8. Jiang, Y. J., Sun, Q., Fang, X. S., and Wang, X. (2009) Comparative mitochondrial proteomic analysis of Rji cells exposed to adriamycin Mol. Med. 15, 173-82
9. Chen, Y., Daosukho, C., Opii, W. O., Turner, D. M., Pierce, W. M., Klein, J. B., Vore, M., Butterfield, D. A., and St Clair, D. K. (2006) Redox proteomic identification of oxidized cardiac proteins in adriamycin-treated mice Free Radical Biol. Med. 41, 1470-7 (Pubitemid 44466730)
10. Li, X., Pan, W., Qiu, F., and Qiu, Z. Y. (2006) Proteomic approach to the effect of epirubicin on hepatoma cells at subcellular level Fen Zi Xi Bao Sheng Wu Xue Bao 39, 407-13
11. Möller, A., Malerczyk, C., Völker, U., Stöppler, H., and Maser, E. (2002) Monitoring daunorubicin-induced alterations in protein expression in pancreas carcinoma cells by two-dimensional gel electrophoresis Proteomics 2, 697-705 (Pubitemid 34693570)
12. Hammer, E., Bien, S., Salazar, M. G., Steil, L., Scharf, C., Hildebrandt, P., Schroeder, H. W., Kroemer, H. K., Völker, U., and Ritter, C. A. (2010) Proteomic analysis of doxorubicin-induced changes in the proteome of HepG2cells combining 2-D DIGE and LC-MS/MS approaches Proteomics 10, 99-114
13. Gaal, D. and Hudecz, F. (1998) Low toxicity and high antitumour activity of daunomycin by conjugation to an immunopotential amphoteric branched polypeptide Eur. J. Cancer 34, 155-161 (Pubitemid 28123394)
14. Szabó, R., Bánóczi, Z., Mezo, G., Láng, O., Kohidai, L., and Hudecz, F. (2010) Daunomycin-polypeptide conjugates with antitumor activity Biochim. Biophys. Acta 1798, 2209-16
15. Baurain, R., Masquelier, M., Deprezde, C. D., and Trouet, A. (1983) Targeting of daunorubicin by covalent and reversible linkage to carrier proteins-lysosomal hydrolysis and antitumoral activity of conjugates prepared with peptidic spacer arms Drugs Exp. Clin. Res. 9, 303-311 (Pubitemid 13084948)
16. Nogusa, H., Yano, T., Kashima, N., Yamamoto, K., Okuno, S., and Hamana, H. (2000) Structure-activity relationships of carboxymethylpullulan-peptide- doxorubicin conjugates - systematic modification of peptide spacers Bioorg. Med. Chem. Lett. 10, 227-30 (Pubitemid 30105377)
17. Shiah, J. G., Sun, Y. G., Peterson, C. M., Straight, R. C., and Kopecek, J. (2000) Antitumor activity of N-(2-hydroxypropyl)methacrylamide copolymer-mesochlorin e(6) and adriamycin conjugates in combination treatments Clin. Cancer Res. 6, 1008-1015 (Pubitemid 30159361)
18. Kamada, H., Tsutsumi, Y., Yoshioka, Y., Yamamoto, Y., Kodaira, H., Tsunoda, S., Okamoto, T., Mukai, Y., Shibata, H., Nakagawa, S., and Mayumi, T. (2004) Design of a pH-sensitive polymeric carrier for drug release and its application in cancer therapy Clin. Cancer Res. 10, 2545-2550 (Pubitemid 38445717)
19. Hurwitz, E. (1983) Specific and nonspecific macromolecule drug conjugates for the improvement of cancer-chemotherapy Biopolymers 22, 557-567 (Pubitemid 13125437)
20. Zunino, F., Dimarco, A., and Velcich, A. (1977) Steric influence of orientation of primary amino group at position 3 of sugar moiety of anthracycline antibiotics in DNA binding properties Cancer Lett. 3, 271-275 (Pubitemid 8237552)
21. Langer, M., Kratz, F., Rothen-Rutishauser, B., Wunderli-Allenspach, H., and Beck-Sickinger, A. G. (2001) Novel peptide conjugates for tumor-specific chemotherapy J. Med. Chem. 44, 1341-1348 (Pubitemid 32852109)
22. Rodrigues, P. C. A., Roth, T., Fiebig, H. H., Unger, C., Mulhaupt, R., and Kratz, F. (2006) Correlation of the acid-sensitivity of polyethylene glycol daunorubicin conjugates with their in vitro antiproliferative activity Bioorg. Med. Chem. 14, 4110-4117
23. Yamamoto, K., Acton, E., and Henry, D. (1972) Antitumor activity of some derivatives of daunorubicin at the amino and methyl ketone functions J. Med. Chem. 15, 872-5
24. Patel, L. N., Zaro, J. L., and Shen, W. C. (2007) Cell penetrating peptides: Intracellular pathways and pharmaceutical perspectives Pharm. Res. 24, 1977-1992 (Pubitemid 47493563)
25. Ingallinella, P., Di Marco, A., Taliani, M., Fattori, D., and Pessi, A. (2001) A new method for chemoselective conjugation of unprotected peptides to dauno- and doxorubicin Bioorg. Med. Chem. Lett. 11, 1343-1346 (Pubitemid 32434366)
26. Capobianco, M. L., De Champdoré, M., Arcamone, F., Garbesi, A., Guianvarc'h, D., and B Arimondo, P. (2005) Improved synthesis of daunomycin conjugates with triplex-forming oligonucleotides. The polypurine tract of HIV-1 as a target Bioorg. Med. Chem. 13, 3209-18 (Pubitemid 40462123)
27. Meyer-Losic, F., Quinonero, J., Dubois, V., Alluis, B., Dechambre, M., Michel, M., Cailler, F., Fernandez, A. M., Trouet, A., and Kearsey, J. (2006) Improved therapeutic efficacy of doxorubicin through conjugation with a novel peptide drug delivery technology (Vectocell) J. Med. Chem. 49, 6908-6916 (Pubitemid 44749756)
28. Banoczi, Z., Peregi, B., Orban, E., Szabo, R., and Hudecz, F. (2008) Synthesis of daunomycin-oligoarginine conjugates and their effect on human leukemia cells (HL-60) ARKIVOC 140-153
29. Wong, B. K., Defeo-Jones, D., Jones, R. E., Garsky, V. M., Feng, D. M., Oliff, A., Chiba, M., Ellis, J. D., and Lin, J. H. (2001) PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites Drug Metab. Dispos. 29, 313-318 (Pubitemid 32179533)
30. Rousselle, C., Clair, P., Lefauconnier, J. M., Kaczorek, M., Scherrmann, J. M., and Temsamani, J. (2000) New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy Mol. Pharmacol. 57, 679-686 (Pubitemid 30183706)
31. Mezo, G., Manea, M., Szabo, I., Vincze, B., and Kovacs, M. (2008) New Derivatives of GnRH as Potential Anticancer Therapeutic Agents Curr. Med. Chem. 15, 2366-2379
32. Miklán, Z., Orbán, E., Csík, G., Schlosser, G., Magyar, A., and Hudecz, F. (2009) New daunomycin-oligoarginine conjugates: Synthesis, characterization and effect on human leukemia and human hepatoma cells Biopolymers 6, 489-501
33. Iivanainen, E. and Elenius, K. (2010) ErbB targeted drugs and angiogenesis Curr. Vasc. Pharmacol. 8, 421-31
34. Hynes, N. E. and MacDonald, G. (2009) ErbB receptors and signaling pathways in cancer Curr. Opin. Cell Biol. 21, 177-84
35. Shadidi, M. and Sioud, M. (2003) Selective targeting of cancer cells using synthetic peptides Drug Resist. Updates 6, 363-71 (Pubitemid 38173587)
36. Hung, M. C., Hortobagyi, G. N., and Ueno, N. T. (2000) Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer Adv. Exp. Med. Biol. 465, 171-80 (Pubitemid 32193333)
37. Alaoui-Jamali, M. A. and Qiang, H. (2003) The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery Drug Resist. Updates 6, 95-107 (Pubitemid 36565768)
38. Klapper, L. N., Kirschbaum, M. H., Sela, M., and Yarden, Y. (2000) Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors Adv. Cancer Res. 77, 25-79 (Pubitemid 29439302)
39. Shadidi, M. and Sioud, M. (2003) Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells FASEB J. 17, 256-8
40. Wang, X. F., Birringer, M., Dong, L. F., Veprek, P., Low, P., Swettenham, E., Stantic, M., Yuan, L. H., Zobalova, R., Wu, K., Ledvina, M., Ralph, S. J., and Neuzil, J. (2007) A peptide conjugate of vitamin E succinate targets breast cancer cells with high ErbB2 expression Cancer Res. 67, 3337-44 (Pubitemid 46724873)
41. Lochmann, D., Jauk, E., and Zimmer, A. (2004) Drug delivery of oligonucleotides by peptides Eur. J. Pharm. Biopharm. 58, 237-51 (Pubitemid 39037232)
42. Seoane, S., Montero, J. C., Ocana, A., and Pandiella, A. (2010) Effect of multikinase inhibitors on caspase-independent cell death and DNA damage in HER2-overexpressing breast cancer cells J. Natl. Cancer Inst. 102, 1432-46
43. Liu, J., Ahiekpor, A., Li, L., Li, X., Arbuthnot, P., Kew, M., and Feitelson, M. A. (2009) Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer Int. J. Cancer 125, 1894-901
44. Orbán, E., Mezõ, G., Schlage, P., Csík, G., Kuli?, Z., Ansorge, P., Fellinger, E., Möller, H. M., and Manea, M. (2010) In vitro degradation and antitumor activity of oxime bond-linked daunorubicin-GnRH-III bioconjugates and DNA-binding properties of daunorubicin-amino acid metabolites Amino Acids 2, 469-483
45. Chaires, J. B., Dattagupta, N., and Crothers, D. M. (1982) Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on interaction of daunomycin with deoxyribonucleic acid Biochemistry 21, 3933-40 (Pubitemid 13237187)
46. McGhee, J. D. and von Hippel, P. H. (1974) Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice J. Mol. Biol. 86, 469-89
47. Collins, S. J., Gallo, R. C., and Gallagher, R. E. (1977) Continuous growth and differentation of human myeloid leukemic-cells in suspension culture Nature 270, 347-349
48. Slater, T. F., Sawyer, B., and Strauli, U. (1963) Studies on succinate-tetrazoliumreductase systems. III. Points of coupling of four different tetrazolium salts Biochim. Biophys. Acta 77, 383-393
49. Alston, R. W., Lasagna, M., Grimsley, G. R., Scholtz, J. M., Reinhart, G. D., and Pace, C. N. (2008) Peptide sequence and conformation strongly influence tryptophan fluorescence Biophys. J. 94, 2280-7
50. Trinks, C., Djerf, E. A., Hallbeck, A. L., Jönsson, J. I., and Walz, T. M. (2010) The pan-ErbB receptor tyrosine kinase inhibitor canertinib induces ErbB-independent apoptosis in human leukemia (HL-60 and U-937) cells Biochem. Biophys. Res. Commun. 393, 6-10